WEBULL
WebtradeDownload

Concentra Group Holdings Parent (CON) Is Drawing Fresh Attention, What Is Behind It?

Simply Wall St · 1d ago

Fresh analyst coverage has pushed Concentra Group Holdings Parent (CON) into focus after Zacks assigned the stock its highest Rank of #1 Strong Buy, highlighting an improved earnings outlook and relatively lower valuation metrics versus peer Medpace.

That analyst attention lands on a stock that has already attracted interest, with the share price up 82.1% year to date and delivering a 70.6% total shareholder return over the past twelve months. This suggests that Concentra Group Holdings Parent’s recent momentum has been building rather than fading as investors reassess its earnings outlook and valuation against peers.

Scan beyond Concentra Group Holdings Parent and see how it stacks up against other hand picked value ideas with solid fundamentals in the 32 high quality undervalued stocks.

For Concentra Group Holdings Parent, the recent surge could mirror improving business fundamentals or it could simply reflect investors crowding into a fresh story. The valuation numbers are where that tension really shows up.

Most Popular Narrative: 11.4% Undervalued

Concentra Group Holdings Parent’s most followed valuation storyline pins fair value at $39.88, a premium to the last close at $35.34. This puts current enthusiasm in the context of a stock still framed as below its modeled worth by that narrative.

Employers are intensifying their focus on workforce health compliance and cost control, creating fertile ground for growth in workplace injury prevention, drug testing, and onsite wellness programs. Concentra's recent scale expansion through acquisitions and enhanced primary care offerings positions the company to capture a greater share of this expanding market, supporting long-term revenue and margin growth.

See why 3 investors see Concentra Group Holdings Parent as 11% undervalued.

That storyline rests on a discount rate of 7.49% and assumes mid single digit annual revenue growth and profit margins close to 10%. Together, these inputs support a fair value estimate of $39.88 per share. Against the current share price of $35.34, that implies the narrative views Concentra Group Holdings Parent as 11.4% undervalued, even after a 70.6% total shareholder return over the past year.

For readers weighing that framework, the key moving parts are the revenue and earnings paths and the multiple applied to those future profits. Analysts behind this view model revenue growth of roughly 6% per year, net income of $270.0m by around 2029 versus $195.0m today, and a future P/E of 23.0x, which they note is below the current P/E applied to the broader US Healthcare sector at 25.0x.

Those assumptions matter because they ask investors to be comfortable with earnings growth that is slower than the broader US market but quicker than Concentra Group Holdings Parent’s 5 year earnings record, where profits declined 3% per year. The same framework also leans on margin improvement from today’s 8.5% net margin to just under 10%, while acknowledging risks around high leverage, elevated general and administrative costs and industry changes such as automation reducing workplace injuries.

Analysts also reference a discounted cash flow outcome, where Concentra Group Holdings Parent at $35.34 is trading below an estimated future cash flow value of $41.30 per share. Combined with the narrative fair value of $39.88, plus a value score of 3 out of 6, the picture that emerges is of a healthcare services provider that screens as good value on several internal checks but still carries debt, execution and industry risks that could challenge those projections.

Result: Fair Value of $39.88 (UNDERVALUED)

Still, the Concentra Group Holdings Parent story can break if high leverage keeps interest costs heavy or if automation and remote work steadily shrink core injury volumes.

Find out about the key risks to this Concentra Group Holdings Parent narrative.

Next Steps

Mixed signals around Concentra Group Holdings Parent can be hard to read, so move quickly from headline impressions to your own evidence based view by checking the 3 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Concentra Group Holdings Parent?

Do not stop with one stock. Use the Simply Wall Street Screener to quickly surface new ideas that fit your style before the next move leaves you behind.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.